May we track your activity on this site?

We use cookies and other trackers to monitor the effectiveness of our ad campaigns. You may withdraw your consent at any time by re-opening these options.

SPECIAL CO-LOCATED SYMPOSIA: IAS-ICCR SYMPOSIUM

JOINT IAS-ICCR SATELLITE Symposium
VISCERAL ADIPOSITY AND RELATED ATHEROGENIC HYPERTRIGLYCERIDEMIA: FROM ETIOLOGY TO CLINICAL MANAGEMENT

 

 

ABOUT THE SYMPOSIUM

There is considerable evidence from several imaging cardiometabolic studies that excess visceral adipose tissue accumulation is associated with a constellation of cardiometabolic abnormalities for which hypertriglyceridemia is a key feature. This satellite symposium will provide an update on visceral obesity as a clinical entity requiring new tools for clinical assessment and management. It will also provide evidence that the hypertriglyceridemia of visceral obesity is particularly atherogenic as it reflects atherogenic dysfunctions in subcutaneous adipose tissue and lipoprotein metabolism, leading to the formation of atherogenic remnants. Therapeutic and preventive options will also be reviewed.

This IAS/ICCR joint satellite symposium is supported by an unrestricted grant from Kowa Company, Ltd.

 

SYMPOSIUM DETAILS

Date: Wednesday, June 13, 2018
Time: 08:30 - 17:30
Location: Room 717, Metro Toronto Convention Centre (MTCC)

 

 

SYMPOSIUM PROGRAM 

TimePresentationSpeaker
08:30 - 09:15 Visceral obesity: the history of a modifiable risk factor that has finally reached the spotlight Yuji Matsuzawa, Japan
09:15 - 10:00 Visceral obesity: a pathophysiology update with a focus on visceral adipose tissue André Tchernof, Canada
10:00 - 10:15 COFFEE BREAK
10:15 - 11:00 Visceral obesity: role of dysfunctional subcutaneous adipose tissue Ulf Smith, Sweden
11:00 - 11:45 Revisiting the atherogenicity of hypertriglyceridemia in the context of visceral obesity and dysfunctional subcutaneous adipose tissue Fredrik Karpe, UK
11:45 - 12:30 Lipoprotein metabolism in visceral obesity (mechanistic insights) Marja-Riitta Taskinen, Finland
12:30 - 13:30 LUNCH
13:30 - 14:15 Using physical activity as modality to treat/prevent visceral obesity Robert Ross, Canada
14:15 - 15:00 Targeting nutritional quality to treat/prevent visceral adiposity Frank B. Hu, USA
15:00 - 15:15 COFFEE BREAK
15:15 - 16:00 Molecular targets to manage the hypertriglyceridemic state of visceral obesity Jean-Charles Fruchart, France
16:00 - 16:45 Pharmacological management of the atherogenic dyslipidemia of visceral obesity Shizuya Yamashita, Japan
16:45 - 17:30 Visceral obesity: a problem that requires clinical and public health solutions

Jean-Pierre Després, Canada